Decoding the Science of Life
Pfizer Inc. (PFE) reported its second-quarter 2026 financial results, delivering a performance that underscored the company’s successful pivot away from its…
The first week of August 2026 is shaping up to be a defining period for the biotechnology and pharmaceutical sectors,…
The biotechnology sector is closely watching the regulatory landscape this August, with several key Prescription Drug User Fee Act (PDUFA)…
Not every important healthcare development arrives as a new drug approval or a dramatic clinical-data release. Sometimes the real bottleneck…
The most revealing healthcare development of the last two days may not be a new trial result or a new…
One of the most revealing biotech developments of the last forty-eight hours was not a clinical breakthrough but a regulatory…
One of the most overlooked healthcare developments of the last forty-eight hours came not from a drug trial, a reimbursement…
One of the most overlooked healthcare developments of the last forty-eight hours came not from a drug trial, a reimbursement…
The most interesting healthcare-operations development of the last forty-eight hours was LataMed AI and FARMASER entering a memorandum of understanding…
The most interesting healthcare technology development of the last forty-eight hours was Johnson & Johnson receiving FDA market authorization in…
The most interesting biotech development of the last forty-eight hours is not a late-stage efficacy readout or a licensing deal.…
